Japanese
Title2コンパートメントモデル解析に基づく99mTc - MAG3と131I - OIHの薬物動態の比較
Subtitle原著
Authors秀毛範至*, 高塩哲也*, 佐藤順一**, 石川幸雄**, 斉藤泰博*, 山本和香子*, 油野民雄*, 水永光博***, 金子茂男***, 八竹直***, 小川裕二****, 菊池健次郎****, 笹嶋唯博*****, 久保良彦*****
Authors(kana)
Organization*旭川医科大学附属病院放射線科, **中央放射線部核医学部門, ***泌尿器科, ****第一内科, *****第一外科
Journal核医学
Volume33
Number5
Page513-520
Year/Month1996/5
Article原著
Publisher日本核医学会
Abstract「要旨」99mTc-MAG3, 131I-OIHを同時投与した50例を対象に, 血液中の両トレーサの時間放射能データをもとに2コンパートメントモデル解析を施行した. 各モデルパラメータを両トレーサ間で比較した結果, 血液を含む中心コンパートメントから血管外組織を含む末梢コンパートメントへの移行速度定数, 分布容量, クリアランス(血漿クリアランス)において, 131I-OIHが99mTc-MAG3に比し有意に大きい値(p<0.01)を示した. 両トレーサ間での各パラメータの相関を検討した結果, いずれのパラメータ間にも有意な相関(p<0.0002)が認められ, 特にクリアランスにおいて良好な相関(r=0.891, p<0.0001)が認められた. しかし, クリアランス比(MAG3/OIH)と血清クレアチニン濃度との間には有意な負の相関(r=-0.363, p<0.01)が認められ, クリアランスの相関に及ぼす影響は小さいものの, GFR低下域ではクリアランス比が小さくなる傾向が示唆された. これらの結果から, 99mTc-MAG3と131I-OIHの薬物動態は異なるものの, クリアランスにおいては良好な相関が認められ, 99mTc-MAG3クリアランスは, 131I-OIHクリアランスに代わりうる腎機能指標であることが確認された.
Practice臨床医学:一般
Keywords99mTc-MAG3, 131I-OIH, Pharmacokinetics.
English
TitlePharmacokinetics of 99mTc - MAG3 and 131I - OIH : Comparative Study Based on 2 Compartment Model Analysis
SubtitleOriginal Articles
AuthorsNoriyuki SHUKE*, Tetsuya TAKASHIO*, Junichi SATO**, Yukio ISHIKAWA**, Yasuhiro SAITo*, Wakako YAMAMOTO*, Tamio ABURANO*, Mitsuhiro MIZUNAGA***, Shigeo KANEKO***, Sunao YACHIKU***, Yuji OGAWA****, Kenjiro KIKUCHI****, Tadahiro SASAJIMA*****, Yoshihiko KUBO*****
Authors(kana)
Organization*Department of Radiology, **Central Radiology Service, ***Department of Urology, ****First Department of Internal Medicine, *****First Department of Surgery, Asahikawa Medical College Hospital
JournalThe Japanese Journal of nuclear medicine
Volume33
Number5
Page513-520
Year/Month1996/5
ArticleOriginal article
PublisherTHE JAPANESE SOCIETY OF NUCLEAR MEDICINE
Abstract[Summary]We studied 50 patients with mild to moderate renal dysfunction to compare pharmacokinetics of 99mTc-MAG3 with that of 131I-OIH. After simultaneous bolus injection of both 99mTc-MAG3 and 131I-OIH, 8-point venous blood sampling was performed from 2 to 44 min post injection. Aliquoted plasma samples were counted for radioactivity along with the injected standard to obtain % injected dose/ml plasma for each tracer. Using obtained time-concentration data, classical 2 compartment model analysis was performed for both tracers to obtain various pharmacokinetic parameters, including distribution volumes(Vds), inter-compartmental rate constants, and plasma clearance. In these parameters, Vd of central compartment, Vd at steady state, central to peripheral inter-compartmental rate constant, and plasma clearance were significantly larger for 131I-OIH. In all parameters, significant correlation was found between 99mTc-MAG3 and 131I-OIH. The best correlation was seen in plasma clearance(r=0.891, p<0.0001). Plasma clearance ratio(99mTc-MAG3/131I-OIH), however, showed weak but significant negative correlation with serum creatinine, although this correlation was not likely to affect the overall correlation of clearance between 131I-OIH and 99mTc-MAG3. From these results, we comfirmed that 99mTc-MAG3 clearance could be used as an alternative to 131I-OIH clearance, although pharmacokinetic behavior of 99mTc-MAG3 was not exactly the same as that of 131I-OIH.
PracticeClinical medicine
Keywords99mTc-MAG3, 131I-OIH, Pharmacokinetics.

【全文PDF】